Literature DB >> 30417443

The absence of Rab27a accelerates the degradation of Melanophilin.

Jong Il Park1, Ji Eun Lee1, Cheol Hwan Myung1, Chan Song Jo1, Hye Sung Jang1, Jae Sung Hwang1.   

Abstract

Melanophilin (Mlph) forms an interaction with Rab27a and the actin-based motor protein MyosinVa (MyoVa) on mature melanosome membranes and the tripartite complex regulates melanosome transport in melanocytes. In this study, we found that Rab27a siRNA decreased Mlph and Rab27a protein levels, but Mlph mRNA levels were not changed. Other Rab27a siRNA sequences also showed the same results. When Rab27a siRNA was treated with melan-a melanocytes, Rab27a protein was decreased within 6 hours and Mlph protein was decreased within 24 hours. To determine whether the absence of Rab27a promotes Mlph degradation, we inhibited protein degradation by treatment with proteasome (MG132) and lysosomal enzyme (E64D and Pepstatin A) inhibitors in melan-a melanocytes. MG132 inhibited the degradation of Mlph, but E64D and Pepstatin A had no effect on Mlph. The absence of Rab27a enhanced ubiquitination of Mlph and induced proteasomal degradation. From these results, we concluded that Mlph interaction with Rab27a is important for Mlph stability and melanosome transport.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Rab27a; interaction; melanophilin; melanosome transport; stability

Mesh:

Substances:

Year:  2019        PMID: 30417443     DOI: 10.1111/exd.13840

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  2 in total

Review 1.  Let it go: mechanisms that detach myosin V from the yeast vacuole.

Authors:  Sara Wong; Lois S Weisman
Journal:  Curr Genet       Date:  2021-06-10       Impact factor: 3.886

2.  A novel function of Prohibitin on melanosome transport in melanocytes.

Authors:  Chan Song Jo; Hye In Park; Hyun Jin Jung; Jong Il Park; Ji Eun Lee; Cheol Hwan Myung; Jae Sung Hwang
Journal:  Theranostics       Date:  2020-03-04       Impact factor: 11.556

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.